证券日报网讯 9月24日晚间，金河生物发布公告称，公司于2025年8月18日召开第六届董事会第二十九 次会议、第六届监事会第二十四次会议，审议通过《关于注销2024年股票期权激励计划部分股票期权的 议案》。根据相关规定，鉴于《激励计划》授予的激励对象中3名在职激励对象2024年度个人绩效考核 结果为差，前述激励对象已获授但尚未行权的合计17.50万份股票期权由公司予以注销。2025年9月24 日，经中国证券登记结算有限责任公司深圳分公司审核确认，上述17.50万份股票期权的注销事宜已办 理完成。 （编辑 任世碧） ...

Core Viewpoint - The animal health sector experienced a decline of 1.49% on September 24, with *ST Lvkang leading the drop, while the overall market indices showed positive performance with the Shanghai Composite Index up by 0.83% and the Shenzhen Component Index up by 1.8% [1][2]. Group 1: Market Performance - The animal health sector's decline was primarily driven by *ST Lvkang, which closed at 28.00, down by 1.16% [2]. - The sector's individual stock performance varied, with notable gainers including Yongshun Biological (+3.72%) and Shilian Biological (+1.69%) [1][2]. Group 2: Trading Volume and Capital Flow - The trading volume for the animal health sector showed significant activity, with Yongshun Biological recording a volume of 24,700 hands and a transaction value of 24.36 million [1]. - The sector saw a net outflow of 75.79 million from institutional investors, while retail investors contributed a net inflow of 42.98 million [2][3]. Group 3: Individual Stock Capital Flow - *ST Lvkang experienced a significant net outflow of 10.63 million from institutional investors, indicating a negative sentiment towards the stock [3]. - Conversely, Shilian Biological had a net inflow of 10.41 million from institutional investors, reflecting stronger institutional interest [3].

Core Insights - The report indicates a narrowing profitability in pig farming while the pet food sector continues to grow [1][5] - The investment rating is maintained as "positive" for the sector [1] Pig Farming - Supply pressure has led to a decline in pig prices, with the average price in July-August 2025 at 14.63 CNY/kg, down from 14.96 CNY/kg in Q2 2025 [5] - The average profitability for self-breeding and purchased piglets in the industry has shifted to losses, with figures of 53.0 CNY/head for self-breeding and -106.7 CNY/head for purchased piglets as of September 19 [5] - The outflow of pigs from listed companies has shown a growth rate of 26.2% in Q2 2025 and 20.0% in July-August 2025 [5] - The report suggests that the ongoing policy guidance for capacity adjustment and weight reduction will likely elevate the price center of pigs in the future [5] - Recommended companies for investment include Muyuan Foods, Wens Foodstuff, Dekang Agriculture, Juxing Agriculture, Shennong Group, Tiankang Biological, and Tangrenshen [5] Animal Health - Demand for animal health products is on the rise, with significant year-on-year growth in various vaccines, such as a 30% increase for swine fever vaccines in July-August 2025 [5] - Companies like Keqian Biological and Ruipu Biological are highlighted for their strong internal growth potential due to new product launches [5] Poultry Farming - The price of white feather chickens has rebounded due to seasonal demand and tighter supply, with an average price of 6.92 CNY/kg as of September 19, 2025 [5] - The report notes a 17.66% year-on-year decrease in the number of breeding chickens updated in the first eight months of 2025, indicating potential long-term benefits for the white feather chicken industry [5] - Recommended companies include Shennong Development and Yisheng Livestock [5] Pet Food Sector - Domestic sales of pet food are driven by consumption upgrades and domestic substitution, with a reported growth rate of 11% across major e-commerce platforms from January to August 2025 [5] - The report highlights the introduction of new products and the strengthening of brand power among leading companies [5] - Recommended companies in the pet food sector include Guibao Pet, Zhongchong Co., Petty Co., and Lusi Co. [5]

Core Viewpoint - The stock price of Pulaike has experienced fluctuations, with a year-to-date increase of 8.94% but a recent decline over various trading periods, indicating potential volatility in the market [2]. Company Overview - Pulaike Bioengineering Co., Ltd. is located in Luoyang, Henan Province, established on June 22, 2002, and listed on May 18, 2015. The company primarily engages in the research, production, and sales of veterinary biological products, chemical drugs, and traditional veterinary medicine [2]. - The revenue composition of Pulaike includes: poultry vaccines and antibodies (41.19%), pig vaccines (32.25%), chemical drugs (21.37%), functional health products (1.79%), pet vaccines (1.38%), and other income sources [2]. Financial Performance - For the first half of 2025, Pulaike achieved operating revenue of 559 million yuan, representing a year-on-year growth of 15.79%. The net profit attributable to the parent company was 116 million yuan, reflecting a significant increase of 57.12% [2]. - Since its A-share listing, Pulaike has distributed a total of 1.057 billion yuan in dividends, with 500 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, Pulaike had 18,000 shareholders, an increase of 4.27% from the previous period. The average circulating shares per person decreased by 4.09% to 19,234 shares [2]. - Among the top ten circulating shareholders, the Guotai Zhongzheng Livestock Breeding ETF ranks as the seventh largest, holding 3.4499 million shares, an increase of 141,400 shares from the previous period [3].

Investment Rating - The report maintains a "Recommended" rating for the agricultural, forestry, animal husbandry, and fishery industry [1] Core Viewpoints - The report emphasizes the ongoing adjustment in the pig industry, highlighting the potential for value reassessment due to production capacity control and low-cost performance realization [3][16] - The poultry sector is expected to see improvements in fundamentals, with a focus on the white feather chicken breeding segment and price trends [4][29] - The animal health sector is witnessing a competitive landscape improvement and technological innovation, with several new products receiving clinical approval [5][37] - The pet economy is thriving, with domestic brands rapidly emerging, indicating sustained profitability improvements in the sector [9][59] Summary by Sections Pig Industry - Continuous deepening of pig price control measures is noted, with a focus on maintaining prices within a reasonable range [3][16] - Current average pig price is 13.15 yuan/kg, with a slight weekly decline [15] - Recommended companies include Muyuan Foods and Wens Foodstuffs, with ongoing recommendations for Juxing Agriculture and Shennong Group [3][16] Poultry Industry - The white feather chicken breeding segment shows potential for improvement, with significant updates in breeding stock [4][29] - Current prices for white feather chicken and related products are stable, with slight fluctuations noted [27][28] Animal Health Industry - The competitive landscape is improving, with notable profit differentiation among leading companies [5][36] - Several new vaccines have received clinical approval, marking significant advancements in the sector [5][37] Planting Industry - Prices for corn and soybean meal have shown a week-on-week decline, with ongoing commercialization of genetically modified seeds benefiting early adopters [7][42] Feed Industry - Feed prices are experiencing fluctuations, with a noted increase in production volume [8][48] - Recommended companies include Haida Group, with a focus on rising industry concentration [8][49] Pet Industry - The pet market is projected to reach 300.2 billion yuan in 2024, with a notable increase in consumer spending on pets [9][58] - Recommended companies in the pet food sector include Guobao Pet and Zhongchong Co., with a focus on the growing pet medical segment [9][59]

Core Points - The animal health sector experienced a decline of 0.36% on September 22, with Jinhe Biology leading the drop [1] - The Shanghai Composite Index closed at 3828.58, up 0.22%, while the Shenzhen Component Index closed at 13157.97, up 0.67% [1] Stock Performance Summary - The following stocks in the animal health sector showed notable performance: - Shoufeng Holdings (002141) closed at 3.94, up 3.14% with a trading volume of 307,400 shares and a turnover of 118 million yuan [1] - ST Lvkang (002868) closed at 28.23, up 2.43% with a trading volume of 24,900 shares and a turnover of 69.04 million yuan [1] - Shengbiotech (600201) closed at 9.11, up 1.22% with a trading volume of 396,800 shares and a turnover of 364 million yuan [1] - Jinhe Biology (002688) closed at 6.74, down 2.18% with a trading volume of 234,800 shares and a turnover of 158 million yuan [2] - Other stocks such as Haili Biology (603718) and Zhongmu Co. (600195) also experienced declines of 1.43% and 1.39% respectively [1][2] Capital Flow Analysis - On that day, the animal health sector saw a net outflow of 53.34 million yuan from institutional investors, while retail investors contributed a net inflow of 67.06 million yuan [2]

Investment Rating - The report indicates a positive investment outlook for the agriculture, forestry, animal husbandry, and fishery sector, highlighting significant profit growth across various sub-sectors [2][11]. Core Insights - The agriculture, forestry, animal husbandry, and fishery sector achieved a substantial year-on-year profit increase of 208% in the first half of 2025, with total net profit reaching 207.8 billion yuan [2][11]. - The sub-sectors with the highest profit growth included seed industry (+1212%), pig farming (+663%), and agricultural product processing (+60%) [2][11]. - The report emphasizes the recovery of profitability in pig farming, driven by improved cost efficiency and increased production volume, despite a slight decline in pig prices [2][17]. - The poultry sector, particularly white feathered chicken, is experiencing pressure due to oversupply and weak demand, while yellow feathered chicken prices have significantly dropped [2][17]. - The pet food industry is noted for its continued growth, with domestic brands gaining market share and profitability, despite challenges in export due to increased tariffs [2][3]. Summary by Sections 1. Overview of the Agriculture, Forestry, Animal Husbandry, and Fishery Sector - The sector's net profit for H1 2025 was 207.8 billion yuan, marking a 208% increase year-on-year [11]. - The second quarter of 2025 also showed a profit increase of 26% compared to the previous year, with notable growth in agricultural product processing and pig farming [15]. 2. Sub-sector Performance 2.1 Pig Farming - The pig farming sector reported a total revenue of 201.9 billion yuan in H1 2025, a 17.9% increase year-on-year, with net profit soaring to 159.24 billion yuan, up 866% [2][17]. - Despite a slight decline in pig prices, the sector benefited from increased production and reduced costs, leading to significant profit improvements [2][17]. 2.2 Poultry Farming - The white feathered chicken sector is stabilizing, with a slight recovery in profitability due to cost improvements, while the yellow feathered chicken sector faces significant price declines [2][17]. 2.3 Pet Food - The pet food sector saw a revenue increase of 21.4% in H1 2025, driven by domestic brand growth and improved profitability [2][3]. 2.4 Animal Health - The animal health sector experienced a revenue increase of 26.44% in H1 2025, with net profit rising by 68.35% [4]. 2.5 Feed - The feed sector reported a revenue increase of 13.3% in H1 2025, with net profit up 29.5% [4]. 2.6 Seed Industry - The seed industry faced challenges with a revenue decline of 9.7% in H1 2025, attributed to falling grain prices [4]. 3. Investment Analysis - The report suggests that the pig farming industry is entering a phase of stable, high-quality development, with potential for significant profit stability and valuation reassessment for leading companies [3][5]. - The pet food sector is expected to continue its long-term growth trajectory, supported by increasing pet ownership and spending [3][5].

Market Overview - On September 19, the animal health sector declined by 0.26% compared to the previous trading day, with the driving force leading the decline [1] - The Shanghai Composite Index closed at 3820.09, down 0.3%, while the Shenzhen Component Index closed at 13070.86, down 0.04% [1] Stock Performance - Notable stock movements included: - *ST Lvkang (002868): Closed at 27.56, up 4.99% with a trading volume of 38,500 shares and a turnover of 105 million yuan [1] - Kexin Biological (688526): Closed at 18.08, up 0.39% with a trading volume of 22,700 shares and a turnover of 40.94 million yuan [1] - Driving Force (838275): Closed at 10.50, down 4.11% with a trading volume of 21,200 shares and a turnover of 22.63 million yuan [2] Capital Flow - The animal health sector experienced a net outflow of 91.4 million yuan from institutional investors, while retail investors saw a net inflow of 70.15 million yuan [2] - The capital flow for individual stocks showed: - RuiPu Biological (300119): Net inflow of 16.56 million yuan from institutional investors, but a net outflow of 21.57 million yuan from retail investors [3] - *ST Lvkang (002868): Net inflow of 6.13 million yuan from institutional investors, with a net outflow of 4.21 million yuan from retail investors [3]

Investment Rating - The report maintains a positive outlook on the agriculture, forestry, animal husbandry, and fishery industry, indicating a "Buy" rating for the sector [2]. Core Insights - In the first half of 2025, the listed companies in the livestock sector experienced a significant recovery in profitability, with a total net profit of 20.78 billion yuan, representing a year-on-year increase of 208% [3][14]. - The sub-industries with the highest profit growth included seed industry (+1212%), pig farming (+663%), and agricultural product processing (+60%) [3][15]. - The report highlights a notable divergence in performance among companies within the sector, driven by industry dynamics and operational conditions [3]. Summary by Sections 1. Overview of the Agriculture, Forestry, Animal Husbandry, and Fishery Sector - The agriculture, forestry, animal husbandry, and fishery sector's net profit for the first half of 2025 reached 20.78 billion yuan, a substantial increase of 208% year-on-year [14]. - The second quarter of 2025 also showed a continued growth trend, with a net profit of 10.84 billion yuan, up 26% year-on-year [18]. 2. Sub-sector Performance Review and Investment Strategy 2.1 Pig Farming - The pig farming sector reported a total revenue of 201.9 billion yuan in the first half of 2025, a year-on-year increase of 17.9%, with net profit reaching 15.92 billion yuan, up 865.5% [21]. - Despite a slight decline in pig prices, companies improved profitability through increased volume and reduced costs, with average breeding costs down by 7.2% [21][33]. 2.2 Poultry Farming - The white feather chicken segment showed signs of stabilization, with revenue growth of 0.6% year-on-year, while the yellow feather chicken segment faced significant price declines, leading to a sharp drop in profitability [3][21]. 2.3 Pet Food - The pet food sector saw a revenue increase of 21.4% year-on-year, driven by domestic brand growth and a favorable pricing environment [3][21]. 2.4 Animal Health - The animal health sector experienced a recovery in demand, with total revenue of 8.61 billion yuan, reflecting a year-on-year increase of 26.44% [5][21]. 2.5 Feed - The feed sector's revenue reached 81.91 billion yuan, up 13.3% year-on-year, benefiting from improved profitability in livestock farming [5][21]. 2.6 Seed Industry - The seed industry faced challenges with a revenue decline of 9.7% year-on-year, attributed to falling grain prices and reduced planting enthusiasm among farmers [5][21]. 3. Investment Analysis and Recommendations - The report suggests that the pig farming industry is entering a phase of stable, high-quality development, with potential for significant profit recovery and valuation reassessment for leading companies [4][6]. - The pet food sector is expected to maintain strong growth, supported by increasing pet ownership and spending per pet [4][6].

Market Overview - The animal health sector experienced a decline of 0.32% on September 17, with Shunlian Biological leading the drop [1] - The Shanghai Composite Index closed at 3876.34, up 0.37%, while the Shenzhen Component Index closed at 13215.46, up 1.16% [1] Individual Stock Performance - ST Lvkang (002868) saw a closing price of 25.00, with a rise of 5.00% and a trading volume of 28,300 lots, totaling a transaction value of 67.72 million [1] - Ruipu Biological (300119) closed at 22.06, up 0.32%, with a trading volume of 78,100 lots and a transaction value of 172 million [1] - Kexin Biological (688526) closed at 18.39, with a slight increase of 0.05% and a trading volume of 30,000 lots, totaling 55.44 million [1] - Other notable declines include Yongshun Biological (10.40, -0.19%), Zhongmu Co. (7.38, -0.27%), and Haili Biological (7.15, -0.28%) [1] Capital Flow Analysis - The animal health sector saw a net outflow of 72.39 million from institutional investors, while retail investors contributed a net inflow of 31.00 million [2] - The overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors showed interest [2] Detailed Capital Flow for Selected Stocks - Ruipu Biological had a net inflow of 3.75 million from institutional investors, but a net outflow of 5.98 million from retail investors [3] - ST Lvkang experienced a net inflow of 2.05 million from institutional investors, with retail investors showing a slight outflow [3] - Shunlian Biological faced a significant net outflow of 20.09 million from institutional investors, while retail investors contributed a net inflow of 13.17 million [3]